Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-VIP Polyclonal Antibody

Catalog #:   PHB93601 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P01282
Overview

Catalog No.

PHB93601

Species reactivity

Human, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human VIP (Tyr29-Pro165).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Vasoactive intestinal polypeptide,Peptide histidine valine 42,VIP,Peptide histidine methioninamide 27,VIP peptides

Purification

Purified by antigen affinity column.

Accession

P01282

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with VIP antibody (PHB93601) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 18 kDa
    Observed MW: 18 kDa
References

Active Immunization Against Inhibin Impaired Spermatogenesis, Plasma Luteinizing Hormone, Pituitary Prolactin mRNA, and Hypothalamic Vasoactive Intestinal Peptide mRNA Expressions in Yangzhou Ganders., PMID:40431506

An efficient bivalent vaccine against duck Tembusu and duck plague viruses based on ribosomal skipping of DHAV-1 2A1 and abundant expression of DPV protein., PMID:40424885

miR-196b strictly regulates and reliably predicts the response to cetuximab in colorectal cancer., PMID:40414859

Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration., PMID:40413463

The protective efficacy of inactivated vaccine against hemorrhagic fever with renal syndrome: A meta-analysis., PMID:40388733

Comparative efficacy and acceptability of novel biologics in the treatment of myasthenia gravis: systematic review and network meta-analysis of randomized trials., PMID:40346603

B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in a Blomia tropicalis-murine model., PMID:40205365

Evaluation of tumorous LCP1 and ADPGK as predictive biomarker for immune-related adverse events in bone and soft tissue sarcomas treated with anti-PD-1 and anti-PD-L1 antibodies., PMID:40189514

Duck plague virus UL47 gene affects the release and cell-to-cell spread of the virus and its deletion strains can provide strong protection for ducks., PMID:40158279

Simplifying ANCA-associated vasculitis classification with ANCA specificity: a retrospective analysis., PMID:40100609

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer., PMID:40055652

[Acquired factor Ⅴ inhibitor induced by surgical trauma complicated with fatal hemorrhage: a case report and literature review]., PMID:40032336

Is ADC a rising star in solid tumor? An umbrella review of systematic reviews and meta-analyses., PMID:40021960

Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial., PMID:39999660

New LFA-1 inhibitor Orientin reduces angiotensin II-induced vascular remodeling., PMID:39993698

Identification and Verification of the Driver Genes for the Formation and Development of Intracranial Aneurysms., PMID:39987975

Comparative efficacy and safety of pyrotinib plus trastuzumab versus trastuzumab plus pertuzumab and trastuzumab monotherapy in neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis., PMID:39986012

Omics data integration analysis identified new biological insights into chronic antibody-mediated rejection (CAMR)., PMID:39979925

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial., PMID:39962074

Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings., PMID:39951137

TIGIT expression in extrahepatic cholangiocarcinoma and its impact on CD8 + T cell exhaustion: implications for immunotherapy., PMID:39939322

Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer., PMID:39926433

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial., PMID:39920148

Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer., PMID:39878898

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II-IVa esophageal cancer: a network meta-analysis., PMID:39871293

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages., PMID:39870636

A biodegradable magnesium alloy promotes subperiosteal osteogenesis via interleukin-10-dependent macrophage immunomodulation., PMID:39862617

Anti-GluK2 antibody-positive autoimmune encephalitis concurrent with multiple myeloma: a case report., PMID:39833741

Efficacy, durability and safety of faricimab for patients with neovascular age-related macular degeneration: 48-week results from the phase 3 LUCERNE China subpopulation., PMID:39818248

A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5., PMID:39800731

A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors., PMID:39789619

Efficacy and safety of camrelizumab for the treatment of cervical cancer: a systematic review and meta-analysis., PMID:39777331

Distribution and neurochemical characterisation of neurons containing neuregulin 1 in the enteric nervous system within the porcine small intestine., PMID:39776680

Comparison of the clinicopathological characteristics of children with anti-neutrophil cytoplasmic antibody-associated vasculitis with/without infection at diagnosis., PMID:39762790

Nanobody-based indirect competitive ELISA for the detection of aflatoxin M1 in dairy products., PMID:39755714

Immunization with OPN5 increased seasonal degradation of reproductive activity in Magang ganders., PMID:39754930

Association between depression and anxiety disorders with euthyroid Hashimoto's thyroiditis: A systematic review and meta-analysis., PMID:39717384

Diagnostic Efficacy of 11 SARS-CoV-2 Serological Assays for COVID-19: A Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy., PMID:39698931

Jingfang Granules alleviates the lipid peroxidation induced ferroptosis in rheumatoid arthritis rats by regulating gut microbiota and metabolism of short chain fatty acids., PMID:39608616

Rubella antibody levels in the healthy Chinese population: a meta-analysis., PMID:39600703

Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors., PMID:39583123

Validation and modification of renal risk score for prediction of long-term kidney survival in patients with MPO-ANCA-associated glomerulonephritis., PMID:39576457

Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma., PMID:39563381

A humanized neutralizing antibody protects against human adenovirus type 7 infection in humanized desmoglein-2 and CD46 double-receptor transgenic mice., PMID:39548554

Accuracy of prostigmin tests in the diagnosis of myasthenia gravis: a meta-analysis., PMID:39544787

Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia: The Randomized, Phase 3 REMAIN-2 Trial., PMID:39505412

Interpreting epidemiologic distribution of total and specific IgE levels for food allergy in Southern China from 2004 to 2023: understanding the mechanisms and focusing on prevention., PMID:39482634

Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament., PMID:39441507

Profile of cross-reactivity to common pollen allergens in Northwest China based on component resolved diagnosis., PMID:39424620

Sensory neurons regulate stimulus-dependent humoral immunity in mouse models of bacterial infection and asthma., PMID:39414787

Datasheet

Document Download

Anti-VIP Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-VIP Polyclonal Antibody [PHB93601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only